TY - JOUR AU - Holmes, R. S. AU - Vaughan, T. L. PY - 2007 DA - 2007// TI - Epidemiology and pathogenesis of esophageal cancer JO - Semin Radiat Oncol VL - 17 UR - https://doi.org/10.1016/j.semradonc.2006.09.003 DO - 10.1016/j.semradonc.2006.09.003 ID - Holmes2007 ER - TY - JOUR AU - Mariette, C. AU - Piessen, G. AU - Triboulet, J. P. PY - 2007 DA - 2007// TI - Therapeutic strategies in oesophageal carcinoma: role of surgery and other modalities JO - Lancet Oncol VL - 8 UR - https://doi.org/10.1016/S1470-2045(07)70172-9 DO - 10.1016/S1470-2045(07)70172-9 ID - Mariette2007 ER - TY - JOUR AU - Bedenne, L. AU - Michel, P. AU - Bouche, O. PY - 2007 DA - 2007// TI - Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102 JO - J Clin Oncol VL - 25 UR - https://doi.org/10.1200/JCO.2005.04.7118 DO - 10.1200/JCO.2005.04.7118 ID - Bedenne2007 ER - TY - JOUR AU - Stahl, M. AU - Stuschke, M. AU - Lehmann, N. PY - 2005 DA - 2005// TI - Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus JO - J Clin Oncol VL - 23 UR - https://doi.org/10.1200/JCO.2005.00.034 DO - 10.1200/JCO.2005.00.034 ID - Stahl2005 ER - TY - BOOK AU - Sobin, L. H. AU - Gospodarowicz, M. K. AU - Wittekind, C. PY - 2010 DA - 2010// TI - TNM classification of malignant tumours PB - Wiley-Blackwell CY - Chichester, West Sussex, UK; Hoboken, NJ ID - Sobin2010 ER - TY - JOUR AU - Lagarde, S. M. AU - ten Kate, F. J. AU - Reitsma, J. B. PY - 2006 DA - 2006// TI - Prognostic factors in adenocarcinoma of the esophagus or gastroesophageal junction JO - J Clin Oncol VL - 24 UR - https://doi.org/10.1200/JCO.2005.04.9445 DO - 10.1200/JCO.2005.04.9445 ID - Lagarde2006 ER - TY - JOUR AU - Lagarde, S. M. AU - ten Kate, F. J. AU - Richel, D. J. PY - 2007 DA - 2007// TI - Molecular prognostic factors in adenocarcinoma of the esophagus and gastroesophageal junction JO - Ann Surg Oncol VL - 14 UR - https://doi.org/10.1245/s10434-006-9262-y DO - 10.1245/s10434-006-9262-y ID - Lagarde2007 ER - TY - JOUR AU - Kihara, C. AU - Seki, T. AU - Furukawa, Y. PY - 2000 DA - 2000// TI - Mutations in zinc-binding domains of p53 as a prognostic marker of esophageal-cancer patients JO - Jpn J Cancer Res VL - 91 UR - https://doi.org/10.1111/j.1349-7006.2000.tb00931.x DO - 10.1111/j.1349-7006.2000.tb00931.x ID - Kihara2000 ER - TY - JOUR AU - Ribeiro, U. AU - Finkelstein, S. D. AU - Safatle-Ribeiro, A. V. PY - 1998 DA - 1998// TI - p53 sequence analysis predicts treatment response and outcome of patients with esophageal carcinoma JO - Cancer VL - 83 UR - https://doi.org/3.0.CO;2-R DO - 3.0.CO;2-R ID - Ribeiro1998 ER - TY - JOUR AU - Ireland, A. P. AU - Shibata, D. K. AU - Chandrasoma, P. PY - 2000 DA - 2000// TI - Clinical significance of p53 mutations in adenocarcinoma of the esophagus and cardia JO - Ann Surg VL - 231 UR - https://doi.org/10.1097/00000658-200002000-00005 DO - 10.1097/00000658-200002000-00005 ID - Ireland2000 ER - TY - JOUR AU - Arber, N. AU - Shapira, I. AU - Ratan, J. PY - 2000 DA - 2000// TI - Activation of c-K-ras mutations in human gastrointestinal tumors JO - Gastroenterology VL - 118 UR - https://doi.org/10.1016/S0016-5085(00)70357-X DO - 10.1016/S0016-5085(00)70357-X ID - Arber2000 ER - TY - JOUR AU - Lievre, A. AU - Bachet, J. B. AU - Boige, V. PY - 2008 DA - 2008// TI - KRAS mutations as an independent prognostic factor in patients with advanced colorectal cancer treated with cetuximab JO - J Clin Oncol VL - 26 UR - https://doi.org/10.1200/JCO.2007.12.5906 DO - 10.1200/JCO.2007.12.5906 ID - Lievre2008 ER - TY - JOUR AU - Schemper, M. AU - Smith, T. L. PY - 1996 DA - 1996// TI - A note on quantifying follow-up in studies of failure time JO - Control Clin Trials VL - 17 UR - https://doi.org/10.1016/0197-2456(96)00075-X DO - 10.1016/0197-2456(96)00075-X ID - Schemper1996 ER - TY - JOUR AU - Bergqvist, A. S. AU - Bergqvist, M. AU - Brattstrom, D. PY - 2001 DA - 2001// TI - Serum p53 autoantibodies as prognostic marker in patients with oesophageal carcinoma JO - Anticancer Res VL - 21 ID - Bergqvist2001 ER - TY - JOUR AU - Schneider, P. M. AU - Stoeltzing, O. AU - Roth, J. A. PY - 2000 DA - 2000// TI - P53 mutational status improves estimation of prognosis in patients with curatively resected adenocarcinoma in Barrett's esophagus JO - Clin Cancer Res VL - 6 ID - Schneider2000 ER - TY - JOUR AU - Shimada, H. AU - Shiratori, T. AU - Takeda, A. PY - 2009 DA - 2009// TI - Perioperative changes of serum p53 antibody titer is a predictor for survival in patients with esophageal squamous cell carcinoma JO - World J Surg VL - 33 UR - https://doi.org/10.1007/s00268-008-9821-4 DO - 10.1007/s00268-008-9821-4 ID - Shimada2009 ER - TY - JOUR AU - Takahashi, K. AU - Miyashita, M. AU - Nomura, T. PY - 2007 DA - 2007// TI - Serum p53 antibody as a predictor of early recurrence in patients with postoperative esophageal squamous cell carcinoma JO - Dis Esophagus VL - 20 UR - https://doi.org/10.1111/j.1442-2050.2007.00656.x DO - 10.1111/j.1442-2050.2007.00656.x ID - Takahashi2007 ER - TY - JOUR AU - Cai, H. Y. AU - Wang, X. H. AU - Tian, Y. PY - 2008 DA - 2008// TI - Changes of serum p53 antibodies and clinical significance of radiotherapy for esophageal squamous cell carcinoma JO - World J Gastroenterol VL - 14 UR - https://doi.org/10.3748/wjg.14.4082 DO - 10.3748/wjg.14.4082 ID - Cai2008 ER - TY - JOUR AU - Hainaut, P. AU - Wiman, K. G. PY - 2009 DA - 2009// TI - 30 years and a long way into p53 research JO - Lancet Oncol VL - 10 UR - https://doi.org/10.1016/S1470-2045(09)70198-6 DO - 10.1016/S1470-2045(09)70198-6 ID - Hainaut2009 ER - TY - JOUR AU - Hagiwara, N. AU - Onda, M. AU - Miyashita, M. PY - 2000 DA - 2000// TI - Detection of circulating anti-p53 antibodies in esophageal cancer patients JO - J Nippon Med Sch VL - 67 UR - https://doi.org/10.1272/jnms.67.110 DO - 10.1272/jnms.67.110 ID - Hagiwara2000 ER - TY - JOUR AU - Shimada, H. AU - Takeda, A. AU - Arima, M. PY - 2000 DA - 2000// TI - Serum p53 antibody is a useful tumor marker in superficial esophageal squamous cell carcinoma JO - Cancer VL - 89 UR - https://doi.org/3.0.CO;2-9 DO - 3.0.CO;2-9 ID - Shimada2000 ER - TY - JOUR AU - Angelopoulou, K. AU - Diamandis, E. P. AU - Sutherland, D. J. PY - 1994 DA - 1994// TI - Prevalence of serum antibodies against the p53 tumor suppressor gene protein in various cancers JO - Int J Cancer VL - 58 UR - https://doi.org/10.1002/ijc.2910580404 DO - 10.1002/ijc.2910580404 ID - Angelopoulou1994 ER - TY - JOUR AU - Lubin, R. AU - Schlichtholz, B. AU - Teillaud, J. L. PY - 1995 DA - 1995// TI - p53 antibodies in patients with various types of cancer: assay, identification, and characterization JO - Clin Cancer Res VL - 1 ID - Lubin1995 ER - TY - JOUR AU - Soussi, T. PY - 2000 DA - 2000// TI - p53 Antibodies in the sera of patients with various types of cancer: a review JO - Cancer Res VL - 60 ID - Soussi2000 ER - TY - STD TI - The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2407/12/119/prepub UR - http://www.biomedcentral.com/1471-2407/12/119/prepub ID - ref25 ER -